한미약품에 대한 신뢰와 사랑을 언제나 보내주시는 고객 여러분께 깊은 감사의 말씀을 드립니다.
Thank you for all your trust and love.
Hanmi Pharm established in 1973 has a motto ‘to develop better drugs for precious lives’ and to advance to the global market as a representative of the Korean Pharmaceutical industry by focusing on R&D.
Hanmi Pharm has achieved the first and greatest new drug licensing deal since 1990’s, and became a pioneer of developing first-in-class drugs in collaboration with global leading pharmaceutical companies.
Especially, Hanmi makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone’s health and improve their quality of life.
Hanmi has received GMP certifications from food and drugs authorities of developed countries and also strives to promote public health by exporting finished products to global pharmaceutical companies based upon differentiated quality management.
Hanmi has adopted the new slogan “Trust Based Management” to illustrate the company ethos of always being trustworthy and transparent in everything we do. Along with this, Hanmi will strive to become a world’s innovative pharmaceutical company.
Hanmi pioneering a new way with spirit of creation and challenge will make every endeavor to lead continuous improvement in order for our nation to become a leading player in global pharmaceutical industry.
We believe our responsibility is to devote ourselves to discover global breakthrough drugs with the goal of repaying the love and support from you. We look forward to your continued partnership with us.
Chief Executive Officer Jae-Hyun Park
Recently, Hanmi has been notified of phishing emails and BEC (Businesss Email Compromise) attacks, pretending to be Hanmi's officer asking for your personal information such as a copy of passport or financial support for new business oppertunities.
Hanmi, or Hanmi's representatives, officers, agents, including but not limited to President, Vice President, CEOs or CFOs, do not send emails asking for your personal information.
Please be aware of these phishing emails and BEC attacks, and do respond to them.